NCT00379561View on ClinicalTrials.gov

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

July 31, 2008

Conditions
Prostate Cancer
Interventions
DRUG

PSA-Activated PSA-PAH1

Trial Locations (1)

76502

Cancer Research Institute of Scott and White, Temple

All Listed Sponsors
lead

Sophiris Bio Corp

INDUSTRY

NCT00379561 - PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter